New approaches to assessing the functional status of patients with chronic obstructive pulmonary disease
https://doi.org/10.18093/0869-0189-2020-30-1-53-60
Abstract
About the Authors
V. N. AbrosimovRussian Federation
Vladimir N. Abrosimov, Doctor of Medicine, Professor, Head of Chair of Therapy and Family Medicine with a Course of Medical and Social Expertise, Department of Additional Professional Education. SPIN: 3212-4620. Researcher ID: S-2818-2016
ul. Vysokovol'tnaya 9, Ryazan, 390026
tel.: (4912) 96-27-93
A. V. Kosyakov
Russian Federation
Aleksey V. Kosyakov, Assistant Lecturer of Hospital Internal Medicine with a Course of Medical and Social Expertise. SPIN: 8096-5899. Researcher ID: X-2649-2018
ul. Vysokovol'tnaya 9, Ryazan, 390026
tel.: (905) 690-55-00
I. B. Ponomareva
Russian Federation
Irina B. Ponomareva, Candidate of Medicine, Аssociate Professor of the General Internal Medicine with a Course of Therapy, Faculty of Continued Medical Education. SPIN: 3984-1944. Researcher ID: D-6849-2018
ul. Vysokovol'tnaya 9, Ryazan, 390026
tel.: (910) 575-39-31
N. N. Peregudova
Russian Federation
Nataliya N. Peregudova, Assistant Lecturer of Hospital Internal Medicine with a Course of Medical and Social Expertise. SPIN: 6639-0651. Researcher ID: N-6210-2019
ul. Vysokovol'tnaya 9, Ryazan, 390026
tel.: (910) 617-26-36
References
1. Global Initiative for Chronic Obstructive Lung Diseases. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2019 Report. Available at: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018WMS.pdf
2. Nizov A.A., Ermachkova A.N., Abrosimov V.N., Ponomareva I.B. [Management of patients with copd: role of evaluation of disease in real clinical practice]. Nauka molodykh (Eruditio Juvenium). 2018; 6 (3): 429–438. DOI:10.23888/HMJ201863429-438 (in Russian).
3. Agusti A.G. Systemic effects of chronic obstructive pulmonary disease. Novartis Found Symp. 2001; 234: 242–249.
4. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2 (1): 50–60. DOI: 10.1513/pats.200411-056SF.
5. Sally J.S., Milo A.P., Vasileios A. et. al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur. Respir. J. 2014; 44 (6): 1447–1478. DOI: 10.1183/09031936.00150414.
6. Zeng G.S., Chen L.C., Fan H.Z. et al. The relationship between steps of 6MWT and COPD severity: a cross-sectional study. Int. J. Chron. Obstruct. Pulm. Dis. 2018; 14: 141–148. DOI: 10.2147/COPD.S188994.
7. Furlanetto K.C., Pinto I.F., Sant'Anna T. et al. Profile of patients with chronic obstructive pulmonary disease classified as physically active and inactive according to different thresholds of physical activity in daily life. Braz. J. Phys. Ther. 2016; 20 (6): 517–524.
8. Salgan M., Vardar-Yagli N., Savci S. et al. Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10: 423–428. DOI: 10.2147/COPD.S78937.
9. Misu S., Kaneko M., Sakai H. et al. Exercise-induced oxygen desaturation as a predictive factor for longitudinal decline in 6-minute walk distance in subjects with COPD. Respir. Care. 2019; 64 (2): 145–152. DOI: 10.4187/respcare.06169
10. Van Gestel A.J., Kohler M., Clarenbach C.F. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov. Med. 2012; 14 (79): 359–368.
11. Akramova E.G. [The features of time characteristics of heart rate variability in chronic obstructive pulmonary disease]. Kazanskiy meditsinskiy zhurnal. 2012; 93 (2): 172–177 (in Russian).
12. Camillo C.A., Pitta F., Possani H.V. et al. Heart rate variability and disease characteristics in patients with COPD. Lung. 2008; 186 (6): 393–401. DOI: 10.1007/s00408-0089105-7.
13. Pokhachevskiy A.L., Lapkin M.M. [Heart beat regulation during load test]. Rossiyskiy mediko-biologicheskiy vestnik imeni akademika I.P. Pavlova. 2014; 22 (4): 47–53. DOI:10.17816/PAVLOVJ2014447-53 (in Russian).
14. Ponikowski P.P., Chua T.P., Francis D.P. et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation. 2001; 104 (6): 2324–2330.
15. Miller M.R., Crapo R., Hankinson J. et al. General considerations for lung function testing. Eur. Respir. J. 2005; 26 (1): 153–161. DOI: 10.1183/09031936.05.00034505.
16. Chuchalin A.G., Aisanov Z.R., Chikina S.Yu. et al. [Federal guidelines of Russian Respiratory Society on spirometry]. Pul'monologiya. 2014; (6): 11–23. DOI: 10.18093/08690189-2014-0-6-11-24 (in Russian).
17. Holland A.E., Spruit M.A., Troosters T. et al. An official European Respiratory Society. American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 2014; 44 (6): 1428–1446. DOI:10.1183/09031936.00150314.
18. Baevskiy R.M. [Heart rate variability analysis: history and philosophy, theory and practice.]. Klinicheskaya informatika i telemeditsina. 2004; 1: 54–64 (in Russian).
19. Baevskiy R.M. [Analysis of heart rate variability in space medicine]. Fiziologiya cheloveka. 2002; 28 (2): 70–82 (in Russian).
20. [American Thoracic Society and European Respiratory Society. Joint pulmonary rehabilitation agreement]. Pul'monologiya. 2007; (1): 12–44 (in Russian).
21. Chuchalin A.G., Aisanov Z.R., Avdeev S.N. et al. [Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease]. Pul'monologiya. 2014; (3): 15–54 (in Russian).
Review
For citations:
Abrosimov V.N., Kosyakov A.V., Ponomareva I.B., Peregudova N.N. New approaches to assessing the functional status of patients with chronic obstructive pulmonary disease. PULMONOLOGIYA. 2020;30(1):53-60. (In Russ.) https://doi.org/10.18093/0869-0189-2020-30-1-53-60